A Conversation with Stephen E. Straus

Photo: Courtesy of National Center for Complementary and Alternative Medicine Stephen E. Straus is the director of the National Center for Complementary and Alternative Medicine (NCCAM), which was formally established in 1999. Prior to this appointment, he was chief of the Laboratory of Clinical Investigation at the National Institute of Allergy and Infectious Diseases. He recently chatted with reporters Brendan A. Maher and Eugene Russo. Q: Do you think there's lingering skepticism about NC

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Stephen E. Straus is the director of the National Center for Complementary and Alternative Medicine (NCCAM), which was formally established in 1999. Prior to this appointment, he was chief of the Laboratory of Clinical Investigation at the National Institute of Allergy and Infectious Diseases. He recently chatted with reporters Brendan A. Maher and Eugene Russo.

Q: Do you think there's lingering skepticism about NCCAM's creation?
A: I think there's very little skepticism left. Over the past few years, the debate went from 'Why would anyone want to study these things?' to 'How can you study these things?' to 'What are the studies showing?' The reality is the scientific community by and large has been enormously supportive of this. Our fellow institutes have been very eager to collaborate with us.

From the side of advocates for complementary and alternative medicine, their initial skepticism that we would be able to do a ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Eugene Russo

    This person does not yet have a bio.

Published In

Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino

Products

Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Explore a Concise Guide to Optimizing Viral Transduction

A Visual Guide to Lentiviral Gene Delivery

Takara Bio
Inventia Life Science

Inventia Life Science Launches RASTRUM™ Allegro to Revolutionize High-Throughput 3D Cell Culture for Drug Discovery and Disease Research

An illustration of differently shaped viruses.

Detecting Novel Viruses Using a Comprehensive Enrichment Panel

Twist Bio